Overall haemostatic potential can be used for estimation of thrombin-activatable fibrinolysis inhibitor-dependent fibrinolysis in vivo and for possible follow-up of recombinant factor VIIa treatment in patients with inhibitors to factor VIII.
Antovic JP, Antovic A, He S, Tengborn L, Blomback M
Haemophilia 2002;8(6):781-786.
Review by Aldouri M
Massive pseudotumour resection with recombinant factor VIIa (NovoSeven) cover.
O’Connell N, Chen J, Byrne M, OShea E, Smyth H, Smith OP
Br J Haematol 2002;116(3):645-648.
Review by